Literature DB >> 14989873

[The study of the invasive biologic behavior of ameloblastoma].

Ming Zhong1, Zi-Juan Li, Jie Wang, Yang-Li Yue, Gang Bao.   

Abstract

OBJECTIVE: To investigate the invasive biologic behavior of ameloblastoma (AB) and to analyze its correlative factors.
METHODS: The specimens of 43 cases of AB (primary AB 16 cases, recurrent AB 21 cases, malignant AB 6 cases) were examined immunohistochemically using the streptavidin-biotin method to determine the expression of E-cadherin (E-cad), matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor (VEGF).
RESULTS: The cells in malignant AB scattered more, grew invasively, and the basal membrane ruptured or lost. The expression of E-cad in AB descended, MMP-2 and MMP-9 were strongly expressed in the epithelia cells of 28/41, 30/43 cases of AB, respectively. The positive rate and intensity of VEGF increased as AB recurred and transformed malignantly. The expression of E-cad, MMP-9 and VEGF were related to recurrence or malignant transformation of AB (r(s) = 0.309, 0.519, 0.381, P < 0.05).
CONCLUSION: AB is a high invasive tumor. The biological behavior of AB is related to lost or abnormal expression of E-cad, the high expression of MMP-2, MMP-9, and VEGF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14989873

Source DB:  PubMed          Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi        ISSN: 1002-0098


  3 in total

1.  Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastoma.

Authors:  Rachmitha Anne; Ening Krisnuhoni; Chusnul Chotimah; Benny Sjarief Latief
Journal:  J Maxillofac Oral Surg       Date:  2013-05-29

2.  Comparison of osteoclastogenesis and local invasiveness of ameloblastoma and keratocystic odontogenic tumor.

Authors:  Natheer H Al-Rawi; Ammar K Al-Siraj; Ahlam H Majeed
Journal:  Eur J Dent       Date:  2018 Jan-Mar

3.  Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.

Authors:  Anxun Wang; Bin Zhang; Hongzhang Huang; Leitao Zhang; Donglin Zeng; Qian Tao; Jianguang Wang; Chaobin Pan
Journal:  BMC Cancer       Date:  2008-06-30       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.